American Academy of Dermatology meeting, February 2002
#2 Skin Sensitivity (moderate risk) Sometimes, the spot where you got the shot can get red or irritated
More Peptides 5-Amino-1MQ (10mg) BPC-157 BPC-157, TB-500, GHK-Cu (Glow Blend) 60mg CJC-1295 (no DAC), Ipamorelin 10mg (Blend) GHK-Cu 50mg Copper Peptide Kisspeptin-10 5mg KPV (Ac-KPV-NH2) 5mg MOTS-c NAD+ Retatrutide peptide Selank 10mg Semax TB-500 (Thymosin Beta-4) (43aa) Tesamorelin 5mg Thymosin Alpha-1 Tirzepatide peptide Properties Molecular Formula CHNOCu Molecular Weight 402.92 Monoisotopic Mass 402.107675 Polar Area 179 Complexity 428 Heavy Atom Count 25 Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 7 Rotatable Bond Count 10 PubChem LCSS Identifiers CID 71587328 InChI InChI=1S/C14H24N6O4.Cu/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9;/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24);/q;+2/p-1/t10-,11-;/m0./s1 InChIKey NZWIFMYRRCMYMN-ACMTZBLWSA-M Isometric SMILES C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)[O-])NC(=O)CN.[Cu+2] Canonical SMILES C1=C(NC=N1)CC(C(=O)NC(CCCCN)C(=O)[O-])NC(=O)CN.[Cu+2] IUPAC Name copper (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate Table of content Table of Contents Overview GHK-Cu is a copper-binding peptide complex composed of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine (GHK) and a copper ion
Combined with CJC-1295 without DAC, a growth hormone releasing hormone (GHRH) analog, you amplify and extend your bodys natural growth hormone pulses
How often should copper levels be monitored during GHK-Cu therapy in liver disease
Suggested Mechanisms of Al-Hijamah as a Percutaneous Excretory Procedure That May Clear Serum and Interstitial Fluids of Hepatitis Patients from Disease-Causing Substances Causative pathological substances (CPS) in viral hepatitis (both HBV and HCV infections) include the virus particle itself (B or C especially during stage of viremia), viral antigens (eg, HBs Ag and HBe Ag), viral nucleic acid (DNA in hepatitis B and RNA in hepatitis C), inflammatory cytokines, free radicals and the resultant antigen-antibody complexes (in hepatitis B) (Figure 3)
